SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 254 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $662 | -35.2% | 24,000 | -29.4% | 0.47% | -29.1% |
Q2 2023 | $1,022 | -11.8% | 34,000 | +6.2% | 0.66% | -12.4% |
Q1 2023 | $1,159 | -24.4% | 32,000 | -25.6% | 0.75% | -30.0% |
Q4 2022 | $1,534 | -99.9% | 43,000 | 0.0% | 1.07% | -4.7% |
Q3 2022 | $1,456,000 | +17.0% | 43,000 | 0.0% | 1.12% | +56.3% |
Q2 2022 | $1,244,000 | -99.9% | 43,000 | 0.0% | 0.72% | +14.9% |
Q1 2022 | $1,389,760,000 | +110726.2% | 43,000 | 0.0% | 0.63% | +17.0% |
Q4 2021 | $1,254,000 | +34.4% | 43,000 | +22.9% | 0.54% | +35.8% |
Q3 2021 | $933,000 | +25.2% | 35,000 | +55.6% | 0.39% | +4277.8% |
Q2 2019 | $745,000 | -22.7% | 22,500 | -18.2% | 0.01% | -30.8% |
Q1 2019 | $964,000 | +5.5% | 27,500 | 0.0% | 0.01% | -97.2% |
Q4 2018 | $914,000 | +3.7% | 27,500 | +57.1% | 0.46% | +1740.0% |
Q3 2018 | $881,000 | +9.2% | 17,500 | +29.6% | 0.02% | -94.5% |
Q2 2018 | $807,000 | +30.6% | 13,500 | 0.0% | 0.46% | +9.9% |
Q1 2018 | $618,000 | -53.7% | 13,500 | -59.7% | 0.41% | -56.9% |
Q4 2017 | $1,334,000 | – | 33,500 | – | 0.96% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 426,500 | $11,754,340 | 3.96% |
ASHFORD CAPITAL MANAGEMENT INC | 916,747 | $25,274,715 | 3.72% |
ARMISTICE CAPITAL, LLC | 5,092,000 | $140,386,440 | 2.15% |
S&T BANK/PA | 215,578 | $5,943 | 1.15% |
Aristotle Capital Boston, LLC | 1,187,981 | $32,752,634 | 1.06% |
RICE HALL JAMES & ASSOCIATES, LLC | 544,468 | $15,010,983 | 0.95% |
Tributary Capital Management, LLC | 352,429 | $9,716,468 | 0.92% |
Bridge City Capital, LLC | 65,297 | $1,800,238 | 0.91% |
Integral Health Asset Management, LLC | 220,000 | $6,065,400 | 0.84% |
Retirement Planning Co of New England, Inc. | 51,608 | $1,422,833 | 0.79% |